BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, January 7, 2026
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

FDA accepts Mesoblast’s BLA for pediatric GVHD stem cell therapy under priority review

April 1, 2020
By Tamra Sami
PERTH, Australia –Australian stem cell therapy company Mesoblast Ltd. announced that the FDA has accepted its BLA for priority review for its allogeneic mesenchymal precursor cell therapy, remestemcel-L, for children with acute steroid-refractory graft-vs.-host disease (aGVHD).
Read More

Regulatory front for April 1, 2020

April 1, 2020
The latest global regulatory news, changes and updates affecting biopharma.
Read More

Regulatory actions for April 1, 2020

April 1, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Acasti, Aveo, Concert, Cytodyn, Diurnal, Faron, Mallinckrodt, Mesoblast, Novoteris, Orchard, Y-mabs.
Read More

Other news to note for April 1, 2020

April 1, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Amgen, Astellas, Azurrx, Cardiol, Citius, China Shijiazhuang Pharmaceutical, Daiichi Sankyo, Danaher, Daré, Diffusion, Editas, Eisai, Emergent Biosolutions, Eyepoint, Flexion, GE, Immunitybio, Innovation Pharmaceuticals, Macromoltek, Modalis, Novavax, Novellus, Ocumension, Oramed, Ostrich, Paratek, Regenxbio, Sanbio, Seikagaku, Soleo Health, Sorrento, Ultragenyx, Vaccibody.
Read More

In the clinic for April 1, 2020

April 1, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alligator, Eusa, Horizon, Inflarx, Inmed, Lidds, Novo Nordisk, Oncoceutics, Orchard, Ose, Theranexus.
Read More
3-31-Siemens-RAPIDPoint-500e.png

FDA gives nod to Siemens Healthineers’ Rapidpoint 500e blood gas analyzer

March 31, 2020
By Meg Bryant
Erlangen, Germany-based Siemens Healthineers AG has secured U.S. FDA clearance for its Rapidpoint 500e blood gas analyzer. Available in CE mark countries since August 2019, the device is used to monitor respiratory distress in critically ill patients, such as those in acute care due to COVID-19.
Read More
Europe under magnifier/petri dish with coronavirus

European IVD med-techs upping efforts to launch rapid COVID-19 screening tests

March 31, 2020
By Bernard Banga
PARIS – Europe has turned into the epicenter of the coronavirus pandemic, seeing more than 50% of the cases observed worldwide. In fact, whereas the COVID-19 pandemic has begun declining in China where it originated, there are 400,000 cases of coronavirus worldwide, including more than 200,000 infected by SARS-CoV-2 in the 55 sovereign states in continental Europe, where they are mourning more than 18,000 deaths.
Read More
Cyber eye illustration

Citing COVID-19, Second Sight to wind down operations

March 31, 2020
By Liz Hollis
It has been predicted that the COVID-19 pandemic would cause business disruption. Now, it has claimed a casualty with Second Sight Medical Products Inc., of Sylmar, Calif., which has been forced to wind down operations, citing the pandemic and the impact it will have on the company’s ability to secure financing. Second Sight, which makes the Argus II retinal prosthesis system, said that effective March 31, 84 of its 108 employees will be laid off.
Read More

Regulatory front for March 31, 2020

March 31, 2020
The latest global regulatory news, changes and updates affecting medical devices and technologies, including: Becton Dickinson, Biotechnology Innovation Organization, Cme America, Ortho-Clinical Diagnostics.
Read More

Other news to note for March 31, 2020

March 31, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 3M, Airon, Aroa Biosurgery, Battelle, Behold.ai Technologies, Carterra, Cubic, Dräger, Echosens, Evqlv, Ford, GE Healthcare, General Motors, Houston Methodist Hospital, Immunoprecise Antibodies, JR Automation, Luminati, Luminex, Metaphy Health, Navidea Biopharmaceuticals, Neumodx, Northwell Health, NTI Nanotechnology, Ozo Life, Phillips-Medsize, Procept, Sectra, Sense Biodetection, Stagezero Life Sciences, Viral Protection Labs, Virgin Orbit, Wellbeing Software, Worldcare Clinical.
Read More
Previous 1 2 … 498 499 500 501 502 503 504 505 506 … 551 552 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 7, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 6, 2026.
  • 3D rendering of antibody drug conjugated with cytotoxic payload

    ADCs’ breakout 2025 and their still-unfinished potential

    BioWorld Science
    Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
  • Icons representing scientific research

    Science in 2025: the best of the rest

    BioWorld Science
    A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
  • CAR T cell attacking cancer cells

    Development and characterization of anti-CD19 in vivo CAR T therapy

    BioWorld Science
    Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing